You are here

Home » News

Press Releases from AlphaMed Press

August 8, 2018
Study Shows the Promise of Mesenchymal Stem Cells in Sepsis Therapy

DURHAM, N.C. AUGUST, 2018

A new study published in STEM CELLS, conducted by researchers at the University of Amsterdam, shows how mesenchymal stem cells (MSCs) have multiple immune modulatory properties that could benefit the treatment of sepsis. This study also examines the importance of how MSCs affect inflammatory responses in humans.

Sepsis is a complication caused by the body's overwhelming response to infection and can lead to organ failure. It is a major cause of morbidity and mortality worldwide. Despite the use of antibiotics and well-quipped intensive care facilities, sepsis kills about one in every four patients who contract it.

August 6, 2018
Large Scale Generation of Light-Responsive Human Retinal Organoids

 

DURHAM, N.C. AUGUST, 2018

In a new study published by STEM CELLS, researchers at Newcastle University, UK, describe a new organoid model that encompasses all human retinal cell types and that is responsive to light. Their work could have great impact on finding new treatments for the visually impaired by making drug and toxicology screening faster and more efficient.

Majlinda Lako, PhD Photo
July 30, 2018
Boosting Stem Cells With Growth Factor May Help in Treating Critical Limb Ischemia in Hemodialysis Patients

 

DURHAM, N.C. JULY 2018

A new type of stem cell treatment is showing promise for patients undergoing hemodialysis (HD) who suffer from critical limb ischemia (CLI). Results of a clinical trial, reported on in a recently published article in STEM CELLS Translational Medicine, show that five out of the six patients in the trial were CLI-free one year after treatment.

Dr. Takayasu Ohtake and Dr. Shuzo Kobayashi
July 23, 2018
Study Shows how Stem Cell Injections Helped Dogs suffering from Osteoarthritis

Durham, NC. - July 2018

Researchers have developed what appears to be a simple, minimally invasive, effective way to treat osteoarthritis (OA) in dogs that may prove to be of considerable importance in treating humans, too. The study detailing this new approach appears in the latest issue of STEM CELLS Translational Medicine (SCTM).

Dr. Offer Zeira
July 3, 2018
Enhancing Stem Cells With Oxygen and Forming Them Into Spheroids Leads to Better Bone Repair

 

DURHAM, N.C. JULY, 2018

Depriving stem cells of oxygen and forming them into spheroids before using them to treat bone defects increases their ability to form new bone and repair existing bone, according to a new study in STEM CELLS.

May 10, 2018
Stem Cells Might Provide Breakthrough In Treating Severe Blistering Disease, RDEB

Scientists might be close to a breakthrough in finding a treatment for a severe and devastating skin blistering disease. In a study recently published in STEM CELLS Translational Medicine (SCTM), the team details how they used a certain type of stem cells to significantly relieve the symptoms of recessive dystrophic epidermolysis bullosa (RDEB) in mice.

Mitchell S. Cairo, M.D.

May 4, 2018
Research into Stem Cell-Based Therapies for ARDS Earns Anna Krasnodembskaya the 2017 STEM CELLS Young Investigator Award

Anna D. Krasnodembskaya, Ph.D., has been named STEM CELLS’ Young Investigator of 2017 for her investigations into stem cell-based therapies for acute respiratory distress syndrome (ARDS). The award fosters advancements in the field of stem cells and regenerative medicine by honoring a young researcher who is principle author of an article published in STEM CELLS that is deemed to have the most impact and to push the boundaries of novel and insightful research.

April 30, 2018
Stem Cells Show Long-term Success in Treating Severe Peripheral Arterial Disease

A long-term study of patients who received stem cells to treat angiitis-induced critical limb ischemia (AICLI) shows the cells to be both safe and effective. The study, published in STEM CELLS Translational Medicine (SCTM), could lead to an option for those who suffer from this serious form of peripheral arterial disease (PAD).

March 29, 2018
Stem Cell Discovery Could Aid in Developing Treatments to Control Epileptic Convulsions

A new line of human stem cells shows promise for one day advancing treatment for epileptic seizures. As reported in STEM CELLS Translational Medicine (SCTM), the cells are designed to deliver adenosine – which calms down overexcited neurons and protects them from damage -- to the central nervous system (CNS). The research was conducted by scientists at the University of Bonn and the Central Institute of Mental Health (CIMH) in Mannheim.

March 27, 2018
Study suggests smokers needing stem cell therapy would do better with donated cells

Smoking dramatically decreases the regenerative ability of stem cells, according to a study recently published in the journal STEM CELLS. These findings suggest that a smoker in need of stem cell therapy might fare better if the cells he receives are donated by a nonsmoker — counter to the alternative approach of using the patient’s own stem cells whenever possible to reduce the chance of rejection.

Pages